by Bob Yirka, Medical Xpress Credit: Pixabay/CC0 Public Domain A combined team of researchers from University Roma Tre and Nova Mentis Life Science Corp. has found that administering microdoses of psilocybin to rats with fragile X syndrome (FXS), an autism-like disease, improves some aspects of cognitive performance. In their paper published in the journal Psychopharmacology, the...
